REZOLUTE, INC. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-24: Form 10-K; Period of report 2026-06-30; Description 10-K; Document rzlt-20260630x10k.htm.
- 2025-09-17: Form 10-K; Period of report 2025-06-30; Description 10-K; Document rzlt-20250630x10k.htm.
- 2024-09-19: Form 10-K; Period of report 2024-06-30; Description 10-K; Document rzlt-20240630x10k.htm.
- 2023-09-14: Form 10-K; Period of report 2023-06-30; Description 10-K; Document rzlt-20230630x10k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-24 | 10-K | 2026-06-30 | 10-K | rzlt-20260630x10k.htm |
| 2025-09-17 | 10-K | 2025-06-30 | 10-K | rzlt-20250630x10k.htm |
| 2024-09-19 | 10-K | 2024-06-30 | 10-K | rzlt-20240630x10k.htm |
| 2023-09-14 | 10-K | 2023-06-30 | 10-K | rzlt-20230630x10k.htm |
| 2022-09-15 | 10-K | 2022-06-30 | 10-K | rzlt-20220630x10k.htm |
| 2021-09-15 | 10-K | 2021-06-30 | FORM 10-K | tm2126910d1_10k.htm |
| 2020-10-13 | 10-K | 2020-06-30 | FORM 10-K | tm2024743-1_10k.htm |
| 2019-09-10 | 10-K | 2019-06-30 | FORM 10-K | tv528754_10k.htm |
| 2018-10-15 | 10-K | 2018-06-30 | FORM 10-K | tv503852_10k.htm |
| 2017-09-22 | 10-K | 2017-06-30 | 10-K | v474916_10k.htm |
| 2016-09-28 | 10-K | 2016-06-30 | 10-K | v448917_10k.htm |
| 2015-09-28 | 10-K | 2015-06-30 | FORM 10-K | v420245_10k.htm |
| 2014-09-30 | 10-K | 2014-06-30 | FORM 10-K | v387691_10k.htm |
| 2013-09-11 | 10-K | 2013-06-30 | FORM 10-K | v353844_10k.htm |
| 2012-11-05 | 10-K | 2012-06-30 | FORM 10-K | v327355_10k.htm |
| 2011-09-22 | 10-K | 2011-06-30 | FORM 10-K | v235490_10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |